Unique expression of HRF20 (CD59) in human nervous tissue

被引:11
作者
Akatsu, H
Yamada, T
Okada, N
Yamamoto, T
Yamashina, M
Okada, H
机构
[1] NAGOYA CITY UNIV,SCH MED,DEPT MOL BIOL,MIZUHO KU,NAGOYA,AICHI 467,JAPAN
[2] FUKUSHIMURA HOSP,CHOJU MED INST,TOYOHASHI,AICHI 441,JAPAN
[3] CHIBA UNIV,SCH MED,DEPT NEUROL,CHIBA 260,JAPAN
关键词
HRF20(CD59); DAF(CD55); MCP(CD46); CNS;
D O I
10.1111/j.1348-0421.1997.tb01208.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Damage to autologous tissue by complement is limited by several widely distributed membrane-associated glycoproteins which restrict the action of the complement in homologous species. These include decay accelerating factor (DAF), membrane cofactor protein (MCP) and 20 kDa homologous restriction factor (HRF20,CD59). Using immunohistochemical techniques, we examined the localization of these proteins in the central nervous system (CNS) and peripheral nervous system (PNS) using non-neurological human nervous tissue since some complement components have been demonstrated to be synthesized in the CNS. There was no evidence of parenchymal staining by anti-DAF or anti-MCP antibodies in either type of tissue except for the staining of the endothelium in capillaries. On the other hand, anti-HRF20 antibody clearly stained myelinated axons in the CNS as well as Schwann cells in the PNS. In addition, we detected positive staining by anti-DAF antibody in the PNS of a Paroxysmal nocturnal hemoglobinuria (PNH) patient who is genetically deficient in HRF20.
引用
收藏
页码:321 / 329
页数:9
相关论文
共 42 条
[1]   DECAY-ACCELERATING FACTOR IS PRESENT ON CULTURED HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS [J].
ASCH, AS ;
KINOSHITA, T ;
JAFFE, EA ;
NUSSENZWEIG, V .
JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 163 (01) :221-226
[2]   IMMUNOCYTOCHEMICAL LOCALIZATION OF THE TERMINAL COMPLEMENT COMPLEX IN MULTIPLE-SCLEROSIS [J].
COMPSTON, DAS ;
MORGAN, BP ;
CAMPBELL, AK ;
WILKINS, P ;
COLE, G ;
THOMAS, ND ;
JASANI, B .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1989, 15 (04) :307-316
[3]   ANTIBODY-INDEPENDENT COMPLEMENT ACTIVATION BY MYELIN VIA THE CLASSICAL COMPLEMENT PATHWAY [J].
CYONG, JC ;
WITKIN, SS ;
RIEGER, B ;
BARBARESE, E ;
GOOD, RA ;
DAY, NK .
JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (02) :587-598
[4]   CD59, AN LY-6-LIKE PROTEIN EXPRESSED IN HUMAN LYMPHOID-CELLS, REGULATES THE ACTION OF THE COMPLEMENT MEMBRANE ATTACK COMPLEX ON HOMOLOGOUS CELLS [J].
DAVIES, A ;
SIMMONS, DL ;
HALE, G ;
HARRISON, RA ;
TIGHE, H ;
LACHMANN, PJ ;
WALDMANN, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (03) :637-654
[5]   ACTIVATION OF ALTERNATIVE COMPLEMENT PATHWAY DUE TO RESISTANCE OF ZYMOSAN-BOUND AMPLIFICATION CONVERTASE TO ENDOGENOUS REGULATORY MECHANISMS [J].
FEARON, DT ;
AUSTEN, KF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (04) :1683-1687
[6]   THE MECHANISM OF ACTION OF DECAY-ACCELERATING FACTOR (DAF) DAF INHIBITS THE ASSEMBLY OF C-3 CONVERTASES BY DISSOCIATING C2A AND BB [J].
FUJITA, T ;
INOUE, T ;
OGAWA, K ;
IIDA, K ;
TAMURA, N .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 166 (05) :1221-1228
[7]   HUMAN ASTROCYTES EXPRESS MEMBRANE COFACTOR PROTEIN (CD46), A REGULATOR OF COMPLEMENT ACTIVATION [J].
GORDON, DL ;
SADLON, TA ;
WESSELINGH, SL ;
RUSSELL, SM ;
JOHNSTONE, RW ;
PURCELL, DFJ .
JOURNAL OF NEUROIMMUNOLOGY, 1992, 36 (2-3) :199-208
[8]   EXPRESSION OF CD59, A REGULATOR OF THE MEMBRANE ATTACK COMPLEX OF COMPLEMENT, ON HUMAN ASTROCYTES [J].
GORDON, DL ;
SADLON, T ;
HEFFORD, C ;
ADRIAN, D .
MOLECULAR BRAIN RESEARCH, 1993, 18 (04) :335-338
[9]  
HARADA R, 1990, J IMMUNOL, V144, P1823
[10]  
HIDESHIMA T, 1990, IMMUNOLOGY, V69, P396